These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2509904)

  • 1. Reduced levels of mutagen processing potential in the Schistosoma japonicum-infected mouse liver.
    Matsuoka H; Aji T; Ishii A; Arimoto S; Wataya Y; Hayatsu H
    Mutat Res; 1989 Nov; 227(3):153-7. PubMed ID: 2509904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified metabolism of a carcinogen, 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2), by liver S9 from Schistosoma japonicum-infected mice.
    Arimoto S; Matsuoka H; Aji T; Ishii A; Wataya Y; Hayatsu H
    Mutat Res; 1992 Jul; 282(3):177-82. PubMed ID: 1378550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retention of a mutagen, 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2), in the liver of mice infected with Schistosoma japonicum.
    Aji T; Matsuoka H; Ishii A; Arimoto S; Hayatsu H
    Mutat Res; 1994 Mar; 305(2):265-72. PubMed ID: 7510037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental changes in hepatic activation of dietary mutagens by mice.
    Brennan-Craddock WE; Neale S; Mallett AK; Rowland IR
    Chem Biol Interact; 1989; 71(4):367-79. PubMed ID: 2510945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified mutagen metabolism in Schistosoma hematobium-infested organisms.
    Gentile JM; Brown S; Aardema M; Clark D; Blankespoor H
    Arch Environ Health; 1985; 40(1):5-12. PubMed ID: 3922319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acrylamide as an inducer of metabolic activation system (S9) in rats.
    el-Din AY; al-Maskati HA; Mohamed AY; Dairi MG
    Mutat Res; 1993 Jul; 300(2):91-7. PubMed ID: 7685498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex-dependent induction of hepatic enzymes for mutagenic activation of a tryptophan pyrolysate component, 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]-indole, by feeding in mice.
    Degawa M; Kojima M; Hishinuma T; Hashimoto Y
    Cancer Res; 1985 Jan; 45(1):96-102. PubMed ID: 3880668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine.
    Hietanen E; Malaveille C; Camus AM; Béréziat JC; Brun G; Castegnaro M; Michelon J; Idle JR; Bartsch H
    Drug Metab Dispos; 1986; 14(1):118-26. PubMed ID: 2868854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biotransformation of genotoxic agents in marine sponges. Mechanisms and modulation.
    De Flora S; Bagnasco M; Bennicelli C; Camoirano A; Bojnemirski A; Kurelec B
    Mutagenesis; 1995 Jul; 10(4):357-64. PubMed ID: 7476273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promutagen activation in parasite-infected organisms: preliminary observations with Fasciola hepatica-infected mice and aflatoxin B1.
    Gentile JM; DeRuiter E
    Toxicol Lett; 1981; 8(4-5):273-82. PubMed ID: 6791314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differing activation pathways for 2-acetylaminofluorene to a mutagen in vitro.
    McGregor DB; McConville M; Menzies C; Prentice RD
    Mutat Res; 1982; 102(1):39-50. PubMed ID: 6750372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of liver S9 from 3,4,5,3',4'-pentachlorobiphenyl-pretreated rats on the mutagenic activity of the various carcinogens toward Salmonella typhimurium TA 98.
    Ozawa N; Watabe T; Yoshimura H; Koga N; Shudo K
    J Pharmacobiodyn; 1985 Mar; 8(3):199-205. PubMed ID: 3925118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic activation of the food mutagen 3-amino-1,4-dimethyl-5H-pyrido-[4,3-b]indole (Trp-P-1) in endothelial cells of cytochrome P-450-induced mice.
    Brittebo EB; Brandt I
    Cancer Res; 1994 Jun; 54(11):2887-94. PubMed ID: 8187073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenic activation of aflatoxin B1 by several forms of purified cytochrome P-450.
    Ishii K; Maeda K; Kamataki T; Kato R
    Mutat Res; 1986 Jun; 174(2):85-8. PubMed ID: 3086716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the involvement of N-hydroxylation of 3-amino-1-methyl-5H-pyrido[4,3-b]indole by cytochrome P-450 in the covalent binding to DNA.
    Mita S; Ishii K; Yamazoe Y; Kamataki T; Kato R; Sugimura T
    Cancer Res; 1981 Sep; 41(9 Pt 1):3610-4. PubMed ID: 7020934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apparent activation of 2-acetylaminofluorene and some aromatic amines by cytosolic preparations.
    Forster R; Green MH; Priestley A; Gorrod JW
    Mutat Res; 1981 Aug; 85(4):187-94. PubMed ID: 7022188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cigarette smoke on the mutagenic activation of various carcinogens in hamster.
    Mori Y; Iimura K; Furukawa F; Nishikawa A; Takahashi M; Konishi Y
    Mutat Res; 1995 Jan; 346(1):1-8. PubMed ID: 7530323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of rat liver cytochrome P-450 isozymes in the mutagenic activation of benzo[a]pyrene, aromatic amines and aflatoxin B1.
    Robertson IG; Zeiger E; Goldstein JA
    Carcinogenesis; 1983; 4(1):93-6. PubMed ID: 6295661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mutagenicity of aflatoxin Q1 to Salmonella typhimurium TA 100 with or without rat or human liver microsomal preparations.
    Yourtee DM; Kirk-Yourtee CL
    Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):101-13. PubMed ID: 3099349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hepatic cytochrome P-450 inducing agents on mutagen activity in the host-mediated assay.
    Alldrick AJ; Brennan-Craddock WE; Lake BG; Rowland IR
    Mutat Res; 1992 Aug; 268(2):307-14. PubMed ID: 1379336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.